esketamine nasal spray​

Price range: $250.00 through $950.00

Esketamine Nasal Spray​

esketamine nasal spray​

Esketamine nasal spray, branded as Spravato, is an FDA-approved treatment for treatment-resistant depression (TRD) and major depressive disorder (MDD) with suicidal ideation. It is a fast-acting antidepressant that is typically used in conjunction with oral antidepressants and administered under the supervision of a healthcare provider. esketamine nasal spray​

Each spray device delivers 28 mg of esketamine, with sessions involving doses of 56 mg or 84 mg, depending on the patient’s needs. The treatment is delivered in a clinical setting, as patients must be monitored for about two hours post-administration due to possible side effects such as sedation, dissociation, and increased blood pressure.

Esketamine works differently from traditional antidepressants by targeting NMDA receptors in the brain, which may help alleviate depressive symptoms faster. It is usually used when other treatments have been ineffective.

Common side effects include dizziness, nausea, dissociation, drowsiness, and an increase in blood pressure. It is not intended for home use, and patients are required to stay under medical supervision after each dose to manage any potential side effects. esketamine therapy

SKU: N/A Categories: , , Tags: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,